Meningococcal Immunization Against Gonococcal Infection (MAGI) Trial/ RV564 HU000125CE001
Summary
AI-generated · Sep 28, 2025Meningococcal Immunization Against Gonococcal Infection (MAGI) Trial, RV564, concerns a clinical investigation evaluating whether meningococcal vaccination can prevent gonococcal infection. The record is a justification-type entry and the description field is blank, so no specific scope, tasks, or procurement details are provided here.
No bidding requirements, brand-name constraints, certifications, or site-visit details are disclosed in this entry. An associated award exists in the record, but no funding or scope details are described within this data.